1.56
전일 마감가:
$1.50
열려 있는:
$1.49
하루 거래량:
367.93K
Relative Volume:
0.13
시가총액:
$50.36M
수익:
-
순이익/손실:
$-16.14M
주가수익비율:
-2.8889
EPS:
-0.54
순현금흐름:
$-3.99M
1주 성능:
+4.00%
1개월 성능:
+12.23%
6개월 성능:
-38.82%
1년 성능:
-61.58%
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
명칭
Telomir Pharmaceuticals Inc
전화
786-396-6723
주소
100 SE 2ND ST, MIAMI
TELO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TELO
Telomir Pharmaceuticals Inc
|
1.56 | 50.75M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-21 | 개시 | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스
What technical models suggest about Telomir Pharmaceuticals Inc.’s comeback2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
Forecasting Telomir Pharmaceuticals Inc. price range with options dataJuly 2025 Volume & Fast Gaining Stock Reports - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
How Telomir Pharmaceuticals Inc. stock reacts to global recession fearsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
Why Telomir Pharmaceuticals Inc. stock attracts global investorsMarket Trend Summary & Technical Confirmation Trade Alerts - newser.com
Combining price and volume data for Telomir Pharmaceuticals Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.2025 Biggest Moves & AI Driven Stock Reports - newser.com
What insider trading reveals about Telomir Pharmaceuticals Inc. stockJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - Cincinnati Enquirer
Telomir Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Market reaction to Telomir Pharmaceuticals Inc.’s recent newsPortfolio Growth Summary & Real-Time Chart Pattern Alerts - newser.com
Momentum divergence signals in Telomir Pharmaceuticals Inc. chartVolume Spike & AI Driven Price Forecasts - newser.com
Will Telomir Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Will Telomir Pharmaceuticals Inc. stock benefit from AI adoptionMarket Volume Report & Capital Protection Trade Alerts - Fundação Cultural do Pará
How Telomir Pharmaceuticals Inc. stock compares to growth peersJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Fundação Cultural do Pará
Published on: 2025-10-28 02:03:32 - Fundação Cultural do Pará
Can Telomir Pharmaceuticals Inc. stock withstand economic slowdown2025 Stock Rankings & Proven Capital Preservation Methods - Fundação Cultural do Pará
What dividend safety score for Telomir Pharmaceuticals Inc. stockWeekly Investment Recap & Long Hold Capital Preservation Plans - Fundação Cultural do Pará
Is Telomir Pharmaceuticals Inc. stock a buy on dipsEarnings Summary Report & Daily Profit Focused Stock Screening - Fundação Cultural do Pará
Does Telomir Pharmaceuticals Inc. show high probability of rebound2025 Price Targets & Advanced Swing Trade Entry Alerts - newser.com
Telomir Pharmaceuticals Inc (TELO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):